secwatch.observer — SEC 8-K summary
======================================

Issuer:     China Health Industries Holdings, Inc. (—)
CIK:        0001309057
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001213900-24-062025
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Health sells subsidiary to Chairman Xin Sun for 594k shares and $6k cash
------------------------------------------------------------------------------

- On July 11, 2024, China Health closed the sale of 100% of Harbin Humankind Biology Technology to Chairman/CEO Xin Sun (99%) and his sister Liyuan Sun (1%).
- Consideration: $594,000 paid via transfer of 594,000 shares of CHHE common stock (valued at $1.00/share) from Xin Sun; $6,000 cash from Liyuan Sun.
- The subsidiary Humankind was previously wholly owned by China Health HK; its assets were transferred to another subsidiary (Hankang) prior to the sale.
- This is a related-party transaction; no valuation or financial details of Humankind provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1309057/000121390024062025/0001213900-24-062025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1309057/000121390024062025/ea0209557-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-062025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer